Literature DB >> 2145163

Expression of complement alternative pathway proteins by endothelial cells. Differential regulation by interleukin 1 and glucocorticoids.

H Dauchel1, N Julen, C Lemercier, M Daveau, D Ozanne, M Fontaine, J Ripoche.   

Abstract

We have studied the secretion of proteins of the alternative pathway of complement C3, factor B and factor H by human umbilical vein endothelial cells (HUVEC). Results showed that factor H and factor B are quantitatively secreted in abundance whereas C3 could only be detected when the cells are maintained in culture during long periods of time. Interferon-gamma stimulated factor H, factor B and, to a lesser extent, C3 secretions. Interleukin (IL) 1 had a differential effect on spontaneous C3, factor B and factor H secretions. In the presence of IL 1, there was a significant secretion of C3 occurring within a short period of culture. IL 1 also stimulated factor B secretion. There was a synergistic stimulating effect between IL 1 and interferon-gamma to bring C3 and factor B productions by HUVEC to very high levels. In contrast, factor H secretion was consistently inhibited by IL 1. Local increase in C3 and factor B secretions by endothelial cells in the presence of IL 1 may have important implications in the inflammatory reaction. In striking contrast, the glucocorticoid dexamethasone (DXM) had modulatory effects which are consistent with its anti-inflammatory properties. DXM, at therapeutic concentrations, decreased C3 and factor B secretions and increased factor H secretion. Local modulation of complement protein secretion by DXM appears to be a new mechanism by which this glucocorticoid may control inflammation.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2145163     DOI: 10.1002/eji.1830200808

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  17 in total

1.  Regulation of early complement components C3 and C4 in the synovium.

Authors:  T Collins; J A Winkelstein; K E Sullivan
Journal:  Clin Diagn Lab Immunol       Date:  1996-01

2.  Regulation by retinoic acid of acylation-stimulating protein and complement C3 in human adipocytes.

Authors:  T Scantlebury; A D Sniderman; K Cianflone
Journal:  Biochem J       Date:  2001-06-01       Impact factor: 3.857

3.  The endothelium is an extrahepatic site of synthesis of the seventh component of the complement system.

Authors:  H Langeggen; M Pausa; E Johnson; C Casarsa; F Tedesco
Journal:  Clin Exp Immunol       Date:  2000-07       Impact factor: 4.330

4.  Local and systemic activation of the whole complement cascade in human leukocytoclastic cutaneous vasculitis; C3d,g and terminal complement complex as sensitive markers.

Authors:  H Dauchel; P Joly; A Delpech; E Thomine; F Sauger; X Le Loet; P Lauret; F Tron; M Fontaine; J Ripoche
Journal:  Clin Exp Immunol       Date:  1993-05       Impact factor: 4.330

5.  Pro-inflammatory cytokines from Kupffer cells downregulate hepatocyte expression of adrenomedullin binding protein-1.

Authors:  Asha Jacob; Mian Zhou; Rongqian Wu; Vivienne J Halpern; Thanjavur S Ravikumar; Ping Wang
Journal:  Biochim Biophys Acta       Date:  2007-04-06

6.  The effect of dexamethasone on human mucin 1 expression and antibody-dependent complement sensitivity in a prostate cancer cell line in vitro and in vivo.

Authors:  Masaki Imai; Hee-Young Hwang; James S Norris; Stephen Tomlinson
Journal:  Immunology       Date:  2004-03       Impact factor: 7.397

7.  Effect of interferon-gamma on complement gene expression in different cell types.

Authors:  D F Lappin; D Guc; A Hill; T McShane; K Whaley
Journal:  Biochem J       Date:  1992-01-15       Impact factor: 3.857

8.  Role of protein kinase C activation in synthesis of complement components C2 and factor B in interferon-gamma-stimulated human fibroblasts, glioblastoma cell line A172 and monocytes.

Authors:  I Watanabe; T Horiuchi; S Fujita
Journal:  Biochem J       Date:  1995-01-15       Impact factor: 3.857

9.  Human umbilical vein endothelial cells express complement receptor 1 (CD35) and complement receptor 4 (CD11c/CD18) in vitro.

Authors:  Harald Langeggen; Knut Erik Berge; Egil Johnson; Geir Hetland
Journal:  Inflammation       Date:  2002-06       Impact factor: 4.092

10.  Modulation of complement gene expression by glucocorticoids.

Authors:  D F Lappin; K Whaley
Journal:  Biochem J       Date:  1991-11-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.